Impact Of Sex On Clinical Characteristics And In-Hospital Outcomes In A Multi-Ethnic Southeast Asian Population Of Patients Hospitalized For Acute Heart Failure

ASEAN Heart Journal - Tập 22 - Trang 1-6 - 2014
Peter Chang1, Shaw Yang Chia2, Ling Ling Sim2, Fei Gao2, Fong Ling Lee3, Ping Chai1, Raymond Ching-Chiew Wong1, Swee Chong Seow1, Gerard Kui Toh Leong4, Poh Shuan Daniel Yeo5,6, David Sim2, Terrance Chua2, Bernard W.K. Kwok2, Carolyn S.P. Lam1
1National University Health System, Cardiac Department, Singapore, Singapore
2National Heart Centre Singapore, Department of Cardiology, Singapore, Singapore
3Khoo Teck Puat Hospital, Department of Cardiology, Singapore, Singapore
4Changi General Hospital, Department of Cardiology, Singapore, Singapore
5Tan Tock Seng Hospital, Department of Cardiology, Singapore, Singapore
6Singapore Cardiac Data Bank, Apex Heart Clinic, Gleneagles Hospital, Singapore, Singapore, Singapore

Tóm tắt

To study sex differences in clinical characteristics and outcomes among multi-ethnic Southeast Asian patients with hospitalized heart failure (HHF). HHF is an important public health problem affecting man and women globally. Reports from Western populations suggest striking sex differences in risk factors and outcomes in HHF. However, this has not been studied in a multi-ethnic Asian population. Using the population-based resources of the Singapore Cardiac Data Bank, we studied 5,703 consecutive cases of HHF admitted across hospitals in the Southeast Asian nation of Singapore from 1st January, 2008 through 31st December, 2009. Women accounted for 46% of total admissions and were characterized by older age (73 vs. 67 years; p<0.001), higher prevalence of hypertension (78.6 vs. 72.1%; p<0.001) or atrial fibrillation (22.2 vs. 18.1%; p<0.001), and lower prevalence of coronary artery disease (33.8 vs. 41.0%; p<0.001) or prior myocardial infarction (14.9 vs. 19.8%; p<0.001). Women were more likely than men to have HHF with preserved ejection fraction (42.5% versus 20.8%, p < 0.001). Women were less likely than men to receive evidencebased therapies at discharge, both in the overall group and in the sub-group with reduced ejection fraction. Women had longer lengths of stay (5.6 vs. 5.1 days; p<0.001) but similar in-hospital mortality and one-year rehospitalization rates compared to men. Independent predictors of mortality or rehospitalization in both men and women included prior myocardial infarction and reduced ejection fraction. Among women alone, additional independent predictors were renal impairment, atrial fibrillation, and diabetes. Prescription of beta-blockers and ACE-inhibitors at discharge was associated with better outcomes. Among multi-ethnic Asian patients with HHF, there are important sex differences in clinical characteristics and prognostic factors. These data may inform sex-specific strategies to improve outcomes of HHF in Southeast Asians.

Tài liệu tham khảo

Chongsuvivatwong V, Phua KH, Yap MT, et al. Health and health-care systems in southeast Asia: diversity and transitions. Lancet 2011;377:429–37. Atherton J, Hayward C, Ahmad W, et al. Patient Characteristics From a Regional Multicenter Database of Acute Decompensated Heart Failure in Asia Pacifi c (ADHERE International-Asia Pacifi c). Journal of Cardiac Failure 2012;18:82–8. Stein GY, Ben-Gal T, Kremer A, et al. Gender-related differences in hospitalized heart failure patients. Eur J Heart Fail 2013. Al Suwaidi J, Al-Qahtani A, Asaad N, Al-Mulla AW, Singh R, Albinali HA. Comparison of women versus men hospitalized with heart failure (from a 20-year registry in a middle-eastern country 1991-2010). The American journal of cardiology 2012;109:395–400. Muzzarelli S, Leibundgut G, Maeder MT, et al. Predictors of early readmission or death in elderly patients with heart failure. Am Heart J 2010;160:308–14. Nieminen MS, Harjola VP, Hochadel M, et al. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 2008;10:140–8. Martinez-Selles M, Doughty RN, Poppe K, et al. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail 2012;14:473–9. Galvao M, Kalman J, DeMarco T, et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail 2006;12:100–7. Gustafsson F. Female sex is associated with a better longterm survival in patients hospitalized with congestive heart failure. European Heart Journal 2004;25:129–35. Hisch EM, Grau-Sepulveda MV, Hernandez AF, et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J 2012;163:430–7. Fonarow GC, Abraham WT, Albert NM, et al. Ageand Gender-Related Differences in Quality of Care and Outcomes of Patients Hospitalized With Heart Failure (from OPTIMIZE-HF). The American journal of cardiology 2009;104:107–15. Chong SA, Abdin E, Sherbourne C, et al. Treatment gap in comomon mental disorders: the Singapore perspective. Epidemiology and Psychiatric Sciences 2012;21:195–202. Baumhakel M, Muller U, Bohm M. Infl uence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 2009;11:299–303. Siirila-Waris K, Lassus J, Melin J, et al. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. European heart journal 2006;27:3011–7. Agvall B, Dahlstrom U. Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences. Scand J Prim Health Care 2001:14–9. Cleland J, Cohen-Solal A, C. AJ, et al. Management of heart faliure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360:1631–39. Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;362:759–66. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARMPreserved Trial. Lancet 2003;362:777–81. Lam CSP, Carson PE, Anand IS, et al. Sex DIfferences in Clinical Characteristics and Outcomes in Elderly Patients With Hear Failur and Preserved Ejection Fraction: The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trail. Circulation Heart Failure 2012;5:571–8.